PHVS
USDPharvaris N.V. Ordinary Shares
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$22.482
Máximo
$22.482
Mínimo
$21.585
Volumen
0.14M
Fundamentos de la Empresa
Capitalización de Mercado
1.4B
Industria
Biotecnología
País
Switzerland
Estadísticas de Negociación
Volumen Promedio
0.19M
Bolsa
NMS
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
Pharvaris to Present Clinical Data at the ACAAI 2025 Annual Scientific Meeting
ZUG, Switzerland, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Pharvaris (NASDAQ:PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living
HC Wainwright & Co. Initiates Coverage On Pharvaris with Buy Rating, Announces Price Target of $60
HC Wainwright & Co. analyst Patrick R. Trucchio initiates coverage on Pharvaris with a Buy rating and announces Price Target of $60.
B of A Securities Upgrades Pharvaris to Neutral, Raises Price Target to $27
B of A Securities analyst Tazeen Ahmad upgrades Pharvaris from Underperform to Neutral and raises the price target from $16 to $27.
Acciones Relacionadas
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.